JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M608197200 on November 29, 2007

J. Biol. Chem., Vol. 283, Issue 4, 1974-1984, January 25, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/4/1974    most recent
M608197200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thompson, C.
Right arrow Articles by Rola-Pleszczynski, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thompson, C.
Right arrow Articles by Rola-Pleszczynski, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Signaling by the Cysteinyl-Leukotriene Receptor 2

INVOLVEMENT IN CHEMOKINE GENE TRANSCRIPTION*

Charles Thompson{ddagger}, Alexandre Cloutier§, Ynuk Bossé{ddagger}, Caroline Poisson{ddagger}, Pierre Larivée§, Patrick P. McDonald§, Jana Stankova{ddagger}, and Marek Rola-Pleszczynski{ddagger}1

From the {ddagger}Immunology Division, Department of Pediatrics, and §Pulmonary Division, Department of Medicine, Faculty of Medicine, Université de Sherbrooke, Sherbrooke, Quebec J1H 5N4, Canada

Cysteinyl-leukotrienes are involved in inflammation and act on at least two G-protein-coupled receptors, CysLT1 and CysLT2. However, the role of the CysLT2 receptor as well as its signaling remain poorly understood. Here we show that leukotriene (LT)C4 induced the production of the chemokine interleukin (IL)-8 in endothelial cells. To further study the signaling cascade involved, HEK293 cells were stably transfected with CysLT2 and used to study the transcriptional regulation of the IL-8 promoter. Stimulation of the cells with increasing concentrations of LTC4 resulted in a time- and concentration-dependent induction of IL-8 transcription and protein synthesis. Use of IL-8 promoter mutants with substitutions in their NF-{kappa}B, AP-1, or NF-IL-6 binding elements revealed an almost total requirement for NF-{kappa}B and AP-1 elements, and a lesser requirement for the NF-IL-6 element. Overexpression of dominant-negative I{kappa}B{alpha} prevented the IL-8 transactivation induced by LTC4. LTC4 stimulation induced NF-{kappa}B and AP-1 DNA binding, which involved the formation of a p50/p65 and a c-JUN·c-FOS complex, respectively. Transfection of the cells with a dominant negative (dn) form of PKC{epsilon} prevented p65 phosphorylation, whereas dnPKC{delta} prevented AP-1 binding. Moreover, dnPKC{delta}, dnPKC{epsilon}, and dnPKC{zeta} prevented LTC4-induced IL-8 transcription in response to LTC4. Our data show for the first time that LTC4 can act via the CysLT2 receptor to transcriptionally activate chemokine production through induction of NF-{kappa}B and AP-1 transcription factors. These findings suggest the potential implication of CysLT2 in the inflammatory response through the modulation of chemokine gene transcription.


Received for publication, August 25, 2006 , and in revised form, November 18, 2007.

* This work was supported in part by grants (to P. P. McD., J. S., and M. R.-P.) and studentships (to C. T., A. C., and Y. B.) from the Canadian Institutes of Health Research and a grant from the Foundation for Research into Children's Diseases. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Recipient of a Canada Research Chair in Inflammation. To whom correspondence should be addressed: 3001 North 12th Ave., Sherbrooke, Quebec J1H 5N4, Canada. Tel.: 819-346-1110 (ext: 14851); Fax: 819-564-5215; E-mail: marek.rola-pleszczynski{at}usherbrooke.ca.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.